331 related articles for article (PubMed ID: 25146913)
1. Ovarian hyperstimulation syndrome and thrombotic events.
Mor YS; Schenker JG
Am J Reprod Immunol; 2014 Dec; 72(6):541-8. PubMed ID: 25146913
[TBL] [Abstract][Full Text] [Related]
2. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report.
Rao AK; Chitkara U; Milki AA
Hum Reprod; 2005 Dec; 20(12):3307-12. PubMed ID: 16085662
[TBL] [Abstract][Full Text] [Related]
3. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis following ovarian hyperstimulation syndrome.
Kasum M; Danolić D; Orešković S; Ježek D; Beketić-Orešković L; Pekez M
Gynecol Endocrinol; 2014 Nov; 30(11):764-8. PubMed ID: 25014487
[TBL] [Abstract][Full Text] [Related]
5. The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications.
Chan WS; Dixon ME
Thromb Res; 2008; 121(6):713-26. PubMed ID: 17659766
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of thromboembolism in the course of ovarian hyperstimulation syndrome.
Jóźwik M
Med Wieku Rozwoj; 2012; 16(4):269-71. PubMed ID: 23378404
[TBL] [Abstract][Full Text] [Related]
7. [Thrombotic risk in assisted reproductive technology].
Alatri A; Tribout B; Gencer B; Calanca L; Mazzolai L
Rev Med Suisse; 2011 Feb; 7(281):357-60. PubMed ID: 21416715
[TBL] [Abstract][Full Text] [Related]
8. Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation.
Somigliana E; Peccatori FA; Filippi F; Martinelli F; Raspagliesi F; Martinelli I
Hum Reprod Update; 2014; 20(6):944-51. PubMed ID: 25013217
[TBL] [Abstract][Full Text] [Related]
9. Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH.
Tarlatzis BC; Griesinger G; Leader A; Rombauts L; Ijzerman-Boon PC; Mannaerts BM
Reprod Biomed Online; 2012 Apr; 24(4):410-9. PubMed ID: 22386594
[TBL] [Abstract][Full Text] [Related]
10. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis.
Hignett M; Spence JE; Claman P
Hum Reprod; 1995 Dec; 10(12):3121-3. PubMed ID: 8822426
[TBL] [Abstract][Full Text] [Related]
11. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology.
Chan WS
Curr Opin Obstet Gynecol; 2009 Jun; 21(3):207-18. PubMed ID: 19276806
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
[TBL] [Abstract][Full Text] [Related]
13. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
Smith LP; Hacker MR; Alper MM
Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
[TBL] [Abstract][Full Text] [Related]
14. [Ovarian hyperstimulation syndrome: pathophysiology, risk factors, prevention, diagnosis and treatment].
Lamazou F; Legouez A; Letouzey V; Grynberg M; Deffieux X; Trichot C; Fernandez H; Frydman R
J Gynecol Obstet Biol Reprod (Paris); 2011 Nov; 40(7):593-611. PubMed ID: 21835557
[TBL] [Abstract][Full Text] [Related]
15. Ovarian hyperstimulation syndrome: a clinical retrospective study on 565 inpatients.
Du DF; Li MF; Li XL
Gynecol Endocrinol; 2020 Apr; 36(4):313-317. PubMed ID: 31429334
[TBL] [Abstract][Full Text] [Related]
16. Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.
Wormer KC; Jangda AA; El Sayed FA; Stewart KI; Mumford SL; Segars JH
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():117-124. PubMed ID: 29602141
[TBL] [Abstract][Full Text] [Related]
17. The role of osmoregulation in the pathophysiology and management of severe ovarian hyperstimulation syndrome.
Evbuomwan I
Hum Fertil (Camb); 2013 Sep; 16(3):162-7. PubMed ID: 24047195
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
Bangsbøll S
Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
[TBL] [Abstract][Full Text] [Related]
19. The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review.
Velthuis E; Hubbard J; Longobardi S; D'Hooghe T
Adv Ther; 2020 Dec; 37(12):4831-4847. PubMed ID: 33058045
[TBL] [Abstract][Full Text] [Related]
20. Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis.
Crochet JR; Yeh JS; Clowse ME; Copland SD
Fertil Steril; 2011 Apr; 95(5):1786.e13-6. PubMed ID: 21168129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
